Organic Shilajit Extract
Also known as: Mumie, Mineral Pitch, Organic Shilajit Extract, Shilajit
Overview
Shilajit is a complex natural substance, a tar-like exudate primarily composed of humic substances, including 60-80% fulvic acid, dibenzo-α-pyrones, proteins, and essential minerals like selenium. It is formed over centuries from the decomposition of plant material by microorganisms in mountainous regions, notably the Himalayas. Traditionally, Shilajit has been revered in Ayurvedic medicine for its adaptogenic and antioxidant properties, used to enhance energy, cognitive function, and reproductive health. Modern research focuses on its potential anti-fatigue, anti-inflammatory, and metabolic benefits, largely attributed to its rich fulvic acid content and ability to modulate key signaling pathways such as NF-kB and Nrf2/HO-1. While several clinical trials and systematic reviews support its efficacy and safety, more large-scale, high-quality randomized controlled trials are needed for definitive conclusions.
Benefits
Shilajit offers several evidence-based benefits. For fatigue and muscle strength, an 8-week RCT showed that 250-500 mg daily significantly improved maximal voluntary isometric contraction strength and reduced fatigue-induced strength decline in men, indicating a moderate to large effect size. In reproductive health, a double-blind RCT found that 250 mg Shilajit twice daily for 90 days significantly increased total and free testosterone and DHEAS levels in men aged 45-55, with stabilization of LH and FSH hormones. This benefit is particularly relevant for middle-aged men. For female sexual function, the same study reported significant improvements in Female Sexual Function Index scores over 90 days, though some domains like orgasm and pain remained unchanged. Metabolic benefits include significant reductions in fasting and postprandial blood glucose (24.01% and 20.23% respectively) and improvements in oxidative stress markers in diabetic patients, suggesting its utility for glycemic control. Shilajit also significantly increases antioxidant capacity by up to 97%, enhancing superoxide and hydroxyl radical scavenging activity, and exhibits anti-inflammatory effects via NF-kB and Nrf2/HO-1 modulation. Most studies report benefits after 8 to 12 weeks of daily supplementation.
How it works
Shilajit's mechanism of action is primarily attributed to its rich content of fulvic acid and dibenzo-α-pyrones. These compounds exert potent antioxidant and anti-inflammatory effects by modulating key biological pathways. Shilajit interacts with body systems by enhancing mitochondrial function and energy metabolism, which contributes to its anti-fatigue properties. It supports endocrine regulation, particularly testosterone synthesis, as evidenced by increased testosterone and DHEAS levels. Furthermore, Shilajit reduces oxidative stress in neural and muscular tissues by activating the Nrf2/HO-1 pathway, which upregulates antioxidant enzymes like superoxide dismutase, catalase, and glutathione peroxidase, while simultaneously inhibiting the pro-inflammatory NF-kB pathway. Fulvic acid's water solubility ensures good absorption and bioavailability, allowing its mineral components to contribute to systemic effects.
Side effects
Shilajit is generally considered safe and well-tolerated in clinical trials when used at doses up to 500 mg daily for durations of 8-12 weeks. No significant adverse events have been reported in well-controlled studies. Uncommon or rare side effects are not well documented, and no serious adverse effects have been reported in clinical trials. Traditional use also suggests a low toxicity profile. However, due to its effects on reproductive hormones, caution is advised for individuals with hormone-sensitive conditions. There are no well-documented drug interactions, but individuals on hormone therapies should exercise caution. Shilajit is not recommended for pregnant or breastfeeding women due to the limited safety data available for these specific populations. It is crucial to use purified extracts to avoid contaminants, as unpurified Shilajit can contain heavy metals or other harmful substances.
Dosage
The minimum effective dose for Shilajit has been shown to be 250 mg daily in multiple randomized controlled trials. The optimal dosage range for most benefits is typically 250-500 mg daily, taken for a duration of 8 to 12 weeks. Clinical trials have safely used up to 500 mg daily without reported adverse effects, but long-term safety data beyond 12 weeks is limited. Some studies have utilized a twice-daily dosing regimen, such as 250 mg twice a day. The timing relative to meals is not considered critical for absorption. It is highly recommended to use standardized organic extracts with a defined fulvic acid content to ensure consistency and purity, as this also helps in avoiding contaminants. The water solubility of fulvic acid supports good absorption, and no specific cofactors are identified as necessary for its efficacy.
FAQs
Is Shilajit safe for long-term use?
Limited long-term safety data exists; short-term use up to 12 weeks at recommended dosages appears safe and well-tolerated in clinical studies.
Does Shilajit increase testosterone in all men?
Evidence primarily supports significant increases in total and free testosterone levels in middle-aged men (45-55 years). Effects in younger men are less studied.
Can Shilajit help with diabetes?
Some clinical evidence suggests Shilajit can help reduce fasting and postprandial blood glucose and improve oxidative stress markers in diabetic patients, but more large-scale RCTs are needed.
Is Shilajit effective for female sexual dysfunction?
One study reported significant improvements in Female Sexual Function Index scores in women, but results were mixed across domains, and further research is needed to confirm efficacy.
Are there any known drug interactions with Shilajit?
No well-documented drug interactions exist. However, due to its effects on hormones, caution is advised for individuals on hormone-sensitive medications or therapies.
Research Sources
- https://jptcp.com/index.php/jptcp/article/view/6677 – This systematic review synthesized findings from multiple RCTs, concluding that Shilajit demonstrates clinical efficacy in addressing fatigue, supporting reproductive health, and improving metabolic conditions. It also highlighted Shilajit's generally safe profile, though it noted heterogeneity in study designs and small sample sizes as limitations. The review followed PRISMA guidelines, indicating a moderate quality assessment.
- https://www.ijbcp.com/index.php/ijbcp/article/download/5961/3870/25768 – A double-blind RCT involving 43 men (45-55 years) showed that Shilajit supplementation significantly increased total and free testosterone and DHEAS levels over 90 days. The study also reported improved sexual function in women and no adverse events, indicating a high-quality methodology despite the small sample size and single-center design.
- https://jjbs.hu.edu.jo/files/vol17/n1/Paper%20Number%2010.pdf – This study, combining human clinical data from 48 diabetic patients with animal models, demonstrated significant reductions in fasting and postprandial blood glucose levels (24.01% and 20.23%, respectively) and improvements in oxidative stress markers with Shilajit supplementation. While promising, the moderate quality assessment suggests a need for larger, dedicated clinical trials.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6364418/ – An 8-week RCT with 63 recreationally active men found that Shilajit supplementation (250-500 mg daily) significantly improved maximal voluntary isometric contraction strength and reduced fatigue-induced strength decline. The study's good methodology and controlled design support its findings, though the sample consisted only of young, healthy men.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3296184/ – This review article explored the procognitive activity of Shilajit, suggesting potential neuroprotective and anti-aging effects primarily through its antioxidant pathways. The evidence presented was largely preclinical and from small clinical studies, indicating that these findings are preliminary and require further robust clinical investigation.
